Smoothing approval and enrollment for cancer prevention trials
Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials
This project improves how cancer interception trials are approved and how at-risk patients are found and enrolled so people can access studies that aim to stop cancer early.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11170473 on NIH RePORTER |
What this research studies
From your perspective, the team at the University of Kansas Cancer Center is building clearer, faster processes so prevention trials open and run more smoothly. They will work with the Clinical Trials Office, investigators, and clinics to streamline approvals, patient referral, biomarker testing, and imaging needed for trials. The effort also supports enrolling people into multi-center prevention and vaccine trials, including programs for gastrointestinal cancer risk and Lynch syndrome. Over time this aims to make it easier for patients to hear about and join prevention-focused studies.
Who could benefit from this research
Good fit: Ideal candidates are people at elevated risk for cancer seen at KUCC (for example those with Lynch syndrome or other GI cancer risk factors) who are eligible for prevention or interception trials.
Not a fit: People with no cancer risk factors, those seeking only treatment for advanced cancer, or patients unable to travel to the Kansas City area may not benefit directly from this project.
Why it matters
Potential benefit: If successful, patients could get faster access to prevention trials and more opportunities to take part in studies aiming to stop cancers before they start.
How similar studies have performed: Other centers have improved enrollment by streamlining trial processes, but concentrating on cancer interception and prevention workflows is a relatively new emphasis.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Bansal, Ajay — University of Kansas Medical Center
- Study coordinator: Bansal, Ajay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.